Influenza vaccination for severely multiply handicapped persons/children in the 2005-2006 season

Vaccine

Volumn 25, Issue 23, 2007, Pages 4521-4524

  Otsuka, Taketo ^a   Fujinaka, Hidehiko ^a   Katsuyama, Koichi ^a   Iizawa, Masashi ^a   Kinoshita, Satoru ^a   Tanaka, Yasuki ^a   Saito, Reiko ^b   Suzuki, Hiroshi ^b   Tomizawa, Shuichi ^a  

^a Niigata National Hospital   (Japan)

^b NIIGATA UNIVERSITY   (Japan)

Author keywords

Antibody titer; Influenza vaccine; Severely multiply handicapped persons children

Indexed keywords

INFLUENZA VACCINE; TRIPLE VACCINE;

ADULT; AGED; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DISABLED PERSON; ERYTHEMA; FEMALE; FOLLOW UP; HEMAGGLUTINATION INHIBITION; HUMAN; HYPERTHERMIA; INFLUENZA; INFLUENZA VACCINATION; INJECTION SITE PAIN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPHYLAXIS; RASH; SWELLING;

ADULT; AGED; CHILD; DISABLED CHILDREN; DISABLED PERSONS; FEMALE; HUMANS; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; MALE; MIDDLE AGED; TIME FACTORS; VACCINATION;

EID: 34248397681     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.03.041     Document Type: Article

References (9)

1. WHO FluNet. http://gamapserver.who.int/GlobalAtlas/home.asp.
2. Wilde J.A., McMillan J.A., Serwint J., Butta J., O'Riordan M.A., and Steinhoff M.C. Effectiveness of influenza vaccine in health care professionals: a randomized trial. JAMA 281 (1999) 908-913
3. Reichert T.A., Sugaya N., Fedson D.S., Glezen W.P., Simonsen L., and Tashiro M. The Japanese experience with vaccinating school children against influenza. N Engl J Med 344 (2001) 889-896
4. Palese P. Making better influenza virus vaccines?. Emerg Infect Dis 12 (2006) 61-65
5. Ichinohe T., Watanabe I., Ito S., Fujii H., Moriyama M., Tamura S., et al. Synthetic double-stranded RNA poly (I:C) combined with mucosal vaccine protects against influenza virus infection. J Virol 79 (2005) 2910-2919
6. CDC: Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR; 2006, 55 (RR-10): 1-42.
7. Otsuka T., Fujinaka H., Kamimura T., Tanaka Y., Hayakawa H., Sato M., et al. Influenza vaccination in severely multiply handicapped persons/children. Vaccine 24 (2006) 4096-4101
8. Clements M.L., Betts R.F., Tierney E.L., and Murphy B.R. Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus. J Clin Microbiol 24 (1986) 157-160
9. Dorrell L., Hassan I., Marshall S., Chakraverty P., and Ong E. Clinical and serological responses to an inactivated influenza vaccine in adults with HIV infection, diabetes, obstructive airways disease, elderly adults and healthy volunteers. Int J STD AIDS 8 (1997) 776-779